Corcept's Korlym Defense Unraveling Just as Relacorilant Pipeline Needs to Deliver
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
Corcept reports after market close, meaning Day 0 captures anticipatory trading before results are released, while Day +1 reflects the market's first full session to digest the actual numbers.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-04-30 | -$0.07 (-0.15%) | $1.51 (3.24%) | +$4.90 (+10.53%) | $5.47 (11.75%) |
| 2026-02-24 | +$1.14 (+3.23%) | $2.18 (6.17%) | -$0.26 (-0.71%) | $4.28 (11.72%) |
| 2025-11-04 | -$3.07 (-4.14%) | $4.01 (5.41%) | +$5.55 (+7.81%) | $10.02 (14.09%) |
| 2025-07-31 | -$2.74 (-3.92%) | $3.80 (5.44%) | +$1.83 (+2.72%) | $7.50 (11.17%) |
| 2025-05-05 | +$1.17 (+1.61%) | $2.98 (4.10%) | -$3.20 (-4.33%) | $8.41 (11.37%) |
| 2025-02-26 | +$2.14 (+3.50%) | $2.66 (4.34%) | -$3.52 (-5.55%) | $5.41 (8.54%) |
| 2024-10-30 | -$1.32 (-2.74%) | $2.37 (4.92%) | +$2.08 (+4.44%) | $7.91 (16.87%) |
| 2024-07-29 | +$0.93 (+2.61%) | $1.33 (3.74%) | -$0.41 (-1.12%) | $4.96 (13.58%) |
| Avg Abs Move | 2.74% | 4.67% | 4.65% | 12.38% |
Historical price behavior around Corcept earnings shows significant volatility, with an average absolute Day +1 move of 4.65% and an average intraday range of 12.38% on the day following results. The most recent earnings release (April 2026) exemplifies this pattern: after a modest 0.15% decline on Day 0, the stock surged 10.53% on Day +1 with an 11.75% intraday range—the largest post-earnings rally in the eight-quarter dataset.
The Day 0 moves average 2.74%, suggesting modest anticipatory positioning, but the real action consistently occurs on Day +1 when investors react to results and guidance. Notably, the direction of Day 0 and Day +1 moves frequently diverge—five of the past eight quarters saw reversals between the two sessions—indicating that initial market positioning is often wrong-footed by actual results. The 12.38% average Day +1 range is particularly striking, reflecting sharp intraday swings as traders reassess positions. Given this pattern, investors should prepare for substantial volatility in the session following Tuesday's after-hours release.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 24) |
| Expected Move | $4.46 (4.73%) |
| Expected Range | $89.82 to $98.74 |
| Implied Volatility | 70.87% |
The options market is pricing a 4.73% expected move for the August expiration, which sits slightly above the historical Day 0 average of 2.74% but below the 4.65% average Day +1 move. This suggests options traders may be underpricing the potential volatility, particularly given the 12.38% average Day +1 range that has characterized recent earnings reactions.
Part 3: What Analysts Are Saying
Analysts maintain a bullish stance on Corcept despite the recent earnings challenges, with an average recommendation of 4.00 (Buy) across six analysts. The current consensus includes four Strong Buys, one Hold, and one Strong Sell, reflecting mostly positive sentiment but with emerging skepticism. The average price target of $93.00 sits just below the current price of $94.19, implying minimal upside, though the range is wide—from a low of $50.00 to a high of $135.00—indicating significant disagreement about the company's valuation.
Sentiment has deteriorated over the past month, with the average recommendation declining from 4.43 and the analyst count shifting notably: the Strong Buy contingent dropped from five to four, Holds decreased from two to one, and a new Strong Sell rating appeared. This shift suggests some analysts are losing patience with the earnings trajectory, though the majority still see long-term value in the pipeline and commercial franchise.
The $93.00 consensus target implies essentially flat performance from current levels (1.3% downside), a notably cautious outlook that reflects the near-term earnings uncertainty. However, the $135.00 high target from bullish analysts suggests 43% upside potential for those who believe the company can successfully navigate its current challenges and deliver on its pipeline promise.
Part 4: Technical Picture
Corcept's technical setup heading into earnings is exceptionally strong, with the stock trading above all key moving averages and showing powerful momentum. The Barchart Technical Opinion stands at 100% Buy, up from 88% both a week ago and a month ago, indicating accelerating bullish conviction. This represents the maximum possible reading, reflecting unanimous technical strength across all timeframes and indicators.
Timeframe Analysis:
- Short-term (100% Buy): Maximum buy signal indicates powerful near-term momentum is driving the stock higher into earnings
- Medium-term (100% Buy): Strongest possible reading suggests the intermediate trend is firmly established and supportive
- Long-term (100% Buy): Maximum buy signal reflects exceptional strength in the longer-term trend structure
Trend Characteristics: The combination of Maximum strength and Strengthening direction creates an ideal technical environment, with momentum building across all timeframes as the stock approaches its earnings release.
The stock is trading above all six major moving averages, from the 5-day ($93.64) through the 200-day ($61.35), with particularly impressive separation from longer-term averages—the stock sits 53% above its 200-day moving average. This configuration indicates a sustained uptrend with strong support levels established at each moving average. The progression of moving averages (5-day through 200-day all rising) confirms the trend is intact across all timeframes.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $93.64 | 50-Day MA | $80.62 |
| 10-Day MA | $92.52 | 100-Day MA | $61.52 |
| 20-Day MA | $91.55 | 200-Day MA | $61.35 |
The technical picture is overwhelmingly supportive heading into earnings, with the stock in a powerful uptrend and showing no signs of exhaustion. Key support now sits at the 20-day moving average around $91.55, with stronger support at the 50-day ($80.62) if needed. However, the 53% premium to the 200-day average and the recent surge suggest the stock has priced in considerable optimism—any disappointment in results or guidance could trigger sharp profit-taking given how extended the rally has become. The 100% Buy signal across all timeframes gives bulls confidence, but the magnitude of the advance means there's significant room for downside volatility if the company fails to deliver a credible path back to profitability.